Robert Bona is an Oncology physician affiliated with Yale Cancer Center. OpenAlex indexes 85 publications with 4,694 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
263 Farmington Ave
Farmington, CT 060300001
Telephone
860-679-2100Registry record last updated 15 Jan 2010.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20252 payments
- PFIZER INC.Program year20241 payment
- PFIZER INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
83.8%Factor Xa inhibitor74.7%Eliquis75%Xarelto25%Part D≥39 patientsLow Molecular Weight Heparin5.4%Enoxaparin Sodium100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
12.2%Hydrolytic Lysosomal Glucocerebroside-specific Enzyme6.4%Cerezyme100%Part D<11 patientsGlucosylceramide Synthase Inhibitor5.7%Cerdelga100%Part D<11 patientsCancer & immunology
4.1%Antimetabolite4.1%Hydroxyurea100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2000–2008 per NIH RePORTER. The latest:
- COMPLICATION OF HEMOPHILIA AND SERUM TESTING AND STORAGE
University of Connecticut Sch of Med/dnt
FY2008$1,842M01RR006192 - COMPLICATION OF HEMOPHILIA AND SERUM TESTING AND STORAGE
University of Connecticut Sch of Med/dnt
FY2007$314M01RR006192
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ian Krop, MD
Yale Cancer Center
Natalia Neparidze, MD
Yale Cancer Center
Pamela Kunz, MD
Yale Cancer Center
Jill Lacy, MD
Yale Cancer Center
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”